The CoMPaSS‐NMD Atlas Platform: A Secure Multimodal Infrastructure for Harmonized Data Collection, Exploration, and Future Artificial Intelligence–Driven Stratification in Hereditary Neuromuscular Disorders
11 affiliations
- 1FINCONS GROUP AG Lugano Switzerland
- 2Department of Data Science and Engineering Silesian University of Technology Gliwice Poland
- 3Department of Biomedical, Metabolic and Neural Sciences University of Modena and Reggio Emilia Modena Italy
- 4Friedrich‐Baur‐Institute at the Department of Neurology LMU University Hospital, LMU Medizin, Ludwig‐Maximilians‐Universität München Munich Germany
- 5John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute Newcastle University, and Newcastle Upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne UK
- 6TECNALIA, Basque Research and Technology Alliance (BRTA) Donostia‐San Sebastián Gipuzkoa Spain
- 7Folkhälsan Research Center Helsinki Finland
- 8Deep Blue S.r.l. Rome Italy
- 9Department of Translational Medicine IGBMC (Institut de Génétique et de Biologie Moléculaire et Cellulaire), Inserm U1258, CNRS UMR7104, University of Strasbourg Illkirch France
- 10CeGaT GmbH Tübingen Germany
- 11Molecular Medicine and Neurogenetics Unit IRCCS Fondazione Stella Maris Pisa Italy
Abstract
Background: Hereditary neuromuscular disorders exhibit marked phenotypic and molecular heterogeneity, which weakens genotype–phenotype correlation and complicates timely diagnosis, prognosis, and patient stratification for clinical trials. The Horizon Europe project CoMPaSS‐NMD aims to develop artificial‐intelligence‐based stratification tools by integrating clinical, genetic, histopathological, and imaging data from clinical reference centers across Europe and the United Kingdom.
Methods: We developed CoMPaSS‐NMD Atlas, a secure, modular web platform for pseudonymized data collection, multimodal data management, and controlled exploration. Clinical, technical, and data‐management experts defined requirements; contributing centers co‐designed electronic clinical and histopathology forms. Clinical phenotypes used the Human Phenotype Ontology (HPO), while imaging, histopathology, and sequencing data followed international standards.
Results: The platform supports role‐ and attribute‐based access, pseudonymized patient registration, metadata management, structured clinical data entry, MRI and histopathological uploads, and a dedicated genetic‐sequencing workflow. Cohort‐level exploration is driven by structured metadata and HPO terms, enabling hierarchical phenotype navigation, ontology‐aware data navigation, and cross‐domain queries spanning clinical, genetic, imaging, and histopathological features. Users can download raw files in their original formats, along with structured metadata reports in CSV or PDF, according to the permissions defined for data protection.
Conclusions: The Atlas provides a foundation for harmonized, standardized prospective data collection and for building large datasets for artificial intelligence‐ and machine learning‐based patient stratification. With secure governance, traceability, and multimodal integration, it is designed to support diagnostic and stratification research in hereditary neuromuscular disorders; clinical validation is ongoing.
Related
- Toward comprehensive multimodal health monitoring in heat: A digital biomarker exploration study
- Potential Locations for Noninvasive Brain Stimulation in Treating Poststroke Deficits: Exploration From Multimodal Neuroimaging
- Multimodal Imaging in Anomalous Aortic Origin of the Coronary Arteries: Contemporary Approaches to Risk Stratification.
- Single-center clinical analysis of anomalous aortic origin of a coronary artery (AAOCA) in children: a multimodal imaging approach to risk stratification.
- An interpretable multimodal morphomolecular model refines progression-risk stratification in early-stage endometrioid endometrial carcinoma
BibTeX
@article{corrias2026compassnmd,
title = {{The CoMPaSS‐NMD Atlas Platform: A Secure Multimodal Infrastructure for Harmonized Data Collection, Exploration, and Future Artificial Intelligence–Driven Stratification in Hereditary Neuromuscular Disorders}},
author = {R. Corrias and P. Foszner and A. Nuredini and D. Mendelsohn and A. Töpf and J. Díaz‐Manera and M. Obach and A. Garzo and M. Savarese and J. Verdú‐Díaz and S. Pini and G. La Vella and N. Albano and M. Markiel and L. Piorecki and A. Suwalska and M. Socha and M. Marczyk and S. Bonelli and A. DeAngelis and J. Laporte and G. Caudullo and E. Savino and V. Straub and F. M. Santorelli and J. Polanska and M. P. Scipioni and R. Tupler and B. Schoser},
journal = {European Journal of Neurology},
year = {2026},
month = nov,
doi = {10.1111/ene.70804},
url = {https://doi.org/10.1111/ene.70804},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The CoMPaSS‐NMD Atlas Platform: A Secure Multimodal Infrastructure for Harmonized Data Collection, Exploration, and Future Artificial Intelligence–Driven Stratification in Hereditary Neuromuscular Disorders
AU - R. Corrias
AU - P. Foszner
AU - A. Nuredini
AU - D. Mendelsohn
AU - A. Töpf
AU - J. Díaz‐Manera
AU - M. Obach
AU - A. Garzo
AU - M. Savarese
AU - J. Verdú‐Díaz
AU - S. Pini
AU - G. La Vella
AU - N. Albano
AU - M. Markiel
AU - L. Piorecki
AU - A. Suwalska
AU - M. Socha
AU - M. Marczyk
AU - S. Bonelli
AU - A. DeAngelis
AU - J. Laporte
AU - G. Caudullo
AU - E. Savino
AU - V. Straub
AU - F. M. Santorelli
AU - J. Polanska
AU - M. P. Scipioni
AU - R. Tupler
AU - B. Schoser
PY - 2026
DA - 2026/11/12
JO - European Journal of Neurology
DO - 10.1111/ene.70804
UR - https://doi.org/10.1111/ene.70804
AB - Background: Hereditary neuromuscular disorders exhibit marked phenotypic and molecular heterogeneity, which weakens genotype–phenotype correlation and complicates timely diagnosis, prognosis, and patient stratification for clinical trials. The Horizon Europe project CoMPaSS‐NMD aims to develop artificial‐intelligence‐based stratification tools by integrating clinical, genetic, histopathological, and imaging data from clinical reference centers across Europe and the United Kingdom. Methods: We developed CoMPaSS‐NMD Atlas, a secure, modular web platform for pseudonymized data collection, multimodal data management, and controlled exploration. Clinical, technical, and data‐management experts defined requirements; contributing centers co‐designed electronic clinical and histopathology forms. Clinical phenotypes used the Human Phenotype Ontology (HPO), while imaging, histopathology, and sequencing data followed international standards. Results: The platform supports role‐ and attribute‐based access, pseudonymized patient registration, metadata management, structured clinical data entry, MRI and histopathological uploads, and a dedicated genetic‐sequencing workflow. Cohort‐level exploration is driven by structured metadata and HPO terms, enabling hierarchical phenotype navigation, ontology‐aware data navigation, and cross‐domain queries spanning clinical, genetic, imaging, and histopathological features. Users can download raw files in their original formats, along with structured metadata reports in CSV or PDF, according to the permissions defined for data protection. Conclusions: The Atlas provides a foundation for harmonized, standardized prospective data collection and for building large datasets for artificial intelligence‐ and machine learning‐based patient stratification. With secure governance, traceability, and multimodal integration, it is designed to support diagnostic and stratification research in hereditary neuromuscular disorders; clinical validation is ongoing.
SN - 1351-5101
SN - 1468-1331
ER -